Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis

Introduction: Antipsychotic-induced dyslipidemia represents a common adverse effect faced by patients with schizophrenia that increases risk for developing further metabolic complications and cardiovascular disease. Despite its burden, antipsychotic-induced dyslipidemia is often left untreated, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanagasundaram, Pruntha, Lee, Jiwon, Prasad, Femin, Costa-Dookhan, Kenya A., Hamel, Laurie, Gordon, Madeleine, Remington, Gary, Hahn, Margaret K., Agarwal, Sri Mahavir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010007/
https://www.ncbi.nlm.nih.gov/pubmed/33815174
http://dx.doi.org/10.3389/fpsyt.2021.642403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010007/
https://www.ncbi.nlm.nih.gov/pubmed/33815174
http://dx.doi.org/10.3389/fpsyt.2021.642403

Ejemplares similares